{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-21-000024","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2021-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:21.066592+00:00","generated_at":"2026-06-29T22:56:49.318016+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ICU Medical Q2 revenue $321.7M (+6% YoY); adj. EPS $1.88 vs $1.65","bullets":["GAAP net income $28.4M ($1.31 diluted EPS) vs $18.9M ($0.88) a year ago.","Adjusted EBITDA of $66.9M, up from $58.1M in Q2 2020.","GAAP gross margin improved to 38% from 35% year-over-year.","Company updated FY 2021 guidance in the release."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-21-000024","json":"https://secwatch.observer/filing/0000883984-21-000024.json","markdown":"https://secwatch.observer/filing/0000883984-21-000024.md","text":"https://secwatch.observer/filing/0000883984-21-000024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398421000024/0000883984-21-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398421000024/icui-20210804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T22:56:49.318016+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}